María Lourdes
Vázquez López
Profesora Asociada CC. Salud
Publicaciones en las que colabora con María Lourdes Vázquez López (25)
2022
-
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
Annals of Hematology, Vol. 101, Núm. 9, pp. 2053-2067
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550
2014
-
ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma
Annals of hematology, Vol. 93, Núm. 10, pp. 1745-1753
-
Late differentiation syndrome in acute promyelocytic leukemia: A challenging diagnosis
Hematology Reports, Vol. 6, Núm. 4, pp. 75-77
2010
-
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma
European Journal of Haematology, Vol. 84, Núm. 3, pp. 266-270
2009
-
Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation
Clinical and Experimental Dermatology, Vol. 34, Núm. 8
2005
-
Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia
Leukemia, Vol. 19, Núm. 3, pp. 402-409
2004
-
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma
Bone Marrow Transplantation, Vol. 33, Núm. 6, pp. 579-587
2003
-
Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: Early immunophenotypic evaluation has high clinical value
Blood, Vol. 101, Núm. 12, pp. 4695-4700
2002
-
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
Leukemia, Vol. 16, Núm. 8, pp. 1423-1431
2000
-
Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia
British Journal of Haematology, Vol. 109, Núm. 3, pp. 658-660
-
Cerebral toxoplasmosis and Guillain-Barre syndrome after allogeneic peripheral stem cell transplantation
Transplant Infectious Disease, Vol. 2, Núm. 3, pp. 145-149
1999
-
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation
Bone Marrow Transplantation, Vol. 24, Núm. 12, pp. 1279-1283
-
Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL
British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705
-
Factors that influence long-term hematopoietic function following autologous stem cell transplantation
Bone Marrow Transplantation, Vol. 24, Núm. 3, pp. 289-293
-
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients
Haematologica, Vol. 84, Núm. 3, pp. 231-236
1998
-
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation
Transfusion, Vol. 38, Núm. 4, pp. 385-391
-
Recuperación inmune tras trasplante autólogo de células progenitoras hemopoyéticas. Comparación entre células progenitoras de sangre periférica y de médula ósea
Medicina Clinica, Vol. 110, Núm. 20, pp. 768-773
1997
-
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas
Annals of Hematology, Vol. 74, Núm. 2, pp. 79-82
-
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors
Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458